Pluri Inc.

Israeli company engaged in the development of human placental adherent stromal cells for commercial use

PSTI Tel Aviv Stock Exchange · home listing PJTA Frankfurt SE PLUR Nasdaq SEC CIK 1158780 LEI 529900OZKMF7JGZMYM81
Follow Pluri Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $759K +140.2% vs same quarter last year
Net income −$10.4M −77.6% vs same quarter last year
EPS, diluted −$0.85 −30.8% vs same quarter last year
Operating cash flow −$4.5M +16.2% vs same quarter last year
Revenue by quarter
$185K
$427K
$398K
$316K
$198K
$167K
$335K
$759K
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$60M−$40M−$20M$0$20MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$1M−$23.8M
FY25$1.3M−$22.6M
FY24$326K-
FY23$287K-
FY22$234K−$41.2M
FY21-−$49.9M
FY20$23K−$29.2M
FY19$54K−$35.3M
FY18$50K−$26.1M
FY17-−$27.8M
FY16$2.8M−$23.2M
FY15$379K−$24.7M
FY14$379K−$26.9M
FY13$679K−$21.2M
FY12$716K−$14.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150000%−100000%−50000%0%50000%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2644.6%−2454.5%−2344.6%
FY2549%−1659.9%−1690.3%
FY2498.8%−6796.9%-
FY2396.9%−9493.4%-
FY22100%−17774.8%−17624.8%
FY21---
FY20100%−128156.5%−126747.8%
FY1996.3%−65800%−65383.3%
FY1896%−67462%−52252%
FY17---
FY1696.5%−819.1%−816.5%
FY1596.6%−6666.8%−6511.1%
FY1497.1%−7348.3%−7106.1%
FY1397.1%−3272.9%−3115.6%
FY1297.1%−2099.3%−2066.2%
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26−$20.2M
FY25−$19.8M
FY24−$18.3M
FY23−$23.1M
FY22−$36.8M
FY21−$31.3M
FY20−$26.6M
FY19−$29.7M
FY18−$21.7M
FY17−$22M
FY16−$20.3M
FY15−$21.4M
FY14−$20.7M
FY13−$21.2M
FY12−$4.8M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Pluri
  • Healthcare median
−150000%−100000%−50000%0%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearPluriHealthcare median
FY26−2344.6%−11.1%
FY25−1690.3%−30.6%
FY24-−47%
FY23-−58%
FY22−17624.8%−80.4%
FY21-−71.8%
FY20−126747.8%−62.2%
FY19−65383.3%−46.2%
FY18−52252%−49.6%
FY17-−45.9%
FY16−816.5%−36%
FY15−6511.1%−37.8%
FY14−7106.1%−35.5%
FY13−3115.6%−37.1%
FY12−2066.2%−29.1%